A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : T-ALL / T-cell acute lymphoblastic leukemia/lymphoma

[Related PubMed/MEDLINE]
Total Number of Papers: 39
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   T-ALL  (>> Co-occurring Abbreviation)
Long Form:   T-cell acute lymphoblastic leukemia/lymphoma
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2020 Clinical Experience With Venetoclax Combined With Chemotherapy for Relapsed or Refractory T-Cell Acute Lymphoblastic Leukemia. R/R
2020 Eleven-marker 10-color flow cytometric assessment of measurable residual disease for T-cell acute lymphoblastic leukemia using an approach of exclusion. BM, EOC, EOI, LAIPs, MFC, MRD
2020 Gamma-Delta T-Cell Acute Lymphoblastic Leukemia/Lymphoma: Immunophenotype of Three Adult Cases. T-NHL
2020 Post-induction Measurable Residual Disease Using Multicolor Flow Cytometry Is Strongly Predictive of Inferior Clinical Outcome in the Real-Life Management of Childhood T-Cell Acute Lymphoblastic Leukemia: A Study of 256 Patients. EFS, HR, MFC, MRD, OS, p.i, PC, RFS
2019 Lineage switch from T-cell lymphoblastic leukemia/lymphoma to acute myeloid leukemia and back to T-cell lymphoblastic leukemia/lymphoma in a patient diagnosed during pregnancy. AML, B-ALL
2019 Phenformin, But Not Metformin, Delays Development of T Cell Acute Lymphoblastic Leukemia/Lymphoma via Cell-Autonomous AMPK Activation. ---
2018 Flow cytometric characterization of acute leukemia reveals a distinctive "blast gate" of murine T-lymphoblastic leukemia/lymphoma. CD45dim
2018 Loss of Capicua alters early T cell development and predisposes mice to T cell lymphoblastic leukemia/lymphoma. CIC, SCA1
2018 Notch in Leukemia. CLL, ICN, NRR
10  2017 gammadelta T-Cell Acute Lymphoblastic Leukemia/Lymphoma: Discussion of Two Pediatric Cases and Its Distinction from Other Mature gammadelta T-Cell Malignancies. TCR
11  2017 Notch and its oncogenic activity in human malignancies. GSIs, NICD
12  2016 Distinct oncogenic Ras signals characterized by profound differences in flux through the RasGDP/RasGTP cycle. ---
13  2016 LMO2 Is a Specific Marker of T-Lymphoblastic Leukemia/Lymphoma. LMO2
14  2016 Loss of wild-type Kras promotes activation of all Ras isoforms in oncogenic Kras-induced leukemogenesis. MPN, WT
15  2016 Ribosomal Protein Rpl22 Controls the Dissemination of T-cell Lymphoma. S1PR1
16  2014 Homozygous inv(11)(q21q23) and MLL gene rearrangement in two patients with myeloid neoplasms. ---
17  2014 Unusual T-lymphoblastic blast phase of chronic myelogenous leukemia. CML-CP
18  2013 Dysregulated RasGRP1 responds to cytokine receptor input in T cell leukemogenesis. ---
19  2013 Notch1 gene mutations target KRAS G12D-expressing CD8+ cells and contribute to their leukemogenic transformation. T-LICs
20  2013 The NOTCH signaling pathway: role in the pathogenesis of T-cell acute lymphoblastic leukemia and implication for therapy. GSIs
21  2012 A dominantly acting murine allele of Mcm4 causes chromosomal abnormalities and promotes tumorigenesis. Sdl
22  2012 Overexpression of the anti-apoptotic protein AVEN contributes to increased malignancy in hematopoietic neoplasms. ---
23  2011 Aberrant expression of RasGRP1 cooperates with gain-of-function NOTCH1 mutations in T-cell leukemogenesis. RasGRPs
24  2011 Distinct requirements of hematopoietic stem cell activity and Nras G12D signaling in different cell types during leukemogenesis. HSCs, MPD
25  2011 Endogenous oncogenic Nras mutation initiates hematopoietic malignancies in a dose- and cell type-dependent manner. CMML, TALL
26  2011 Non-lineage/stage-restricted effects of a gain-of-function mutation in tyrosine phosphatase Ptpn11 (Shp2) on malignant transformation of hematopoietic cells. AML, HSCs, JMML, LSCs, MPD, Ptpn11
27  2011 Notch ankyrin repeat domain variation influences leukemogenesis and Myc transactivation. ICN1-4
28  2011 Transient responses to NOTCH and TLX1/HOX11 inhibition in T-cell acute lymphoblastic leukemia/lymphoma. ---
29  2008 Adult precursor T-lymphoblastic leukemia/lymphoma with myeloid-associated antigen expression is associated with a lower complete remission rate following induction chemotherapy. CR
30  2008 Leukemia-associated NOTCH1 alleles are weak tumor initiators but accelerate K-ras-initiated leukemia. ---
31  2008 Oncogenic NOTCH1 control of MYC and PI3K: challenges and opportunities for anti-NOTCH1 therapy in T-cell acute lymphoblastic leukemias and lymphomas. ---
32  2008 Structure of the Notch1-negative regulatory region: implications for normal activation and pathogenic signaling in T-ALL. NRR
33  2007 Chromosomally unstable mouse tumours have genomic alterations similar to diverse human cancers. ---
34  2007 Mutational loss of PTEN induces resistance to NOTCH1 inhibition in T-cell leukemia. PI3K
35  2006 c-Myc is an important direct target of Notch1 in T-cell acute lymphoblastic leukemia/lymphoma. ---
36  2006 Unexpected features of acute T lymphoblastic lymphomas in Notch1IC transgenic rats. ---
37  2005 Deregulated NOTCH signaling in acute T-cell lymphoblastic leukemia/lymphoma: new insights, questions, and opportunities. ICN1
38  2005 Dose-dependent transcriptome changes by metal ores on a human acute lymphoblastic leukemia cell line. MT
39  2000 Essential roles for ankyrin repeat and transactivation domains in induction of T-cell leukemia by notch1. ICN